HIGHLIGHTS
- who: Maria Noflatscher from the Angiology, Department of Internal Medicine III Cardiology, Medical University, Austria, Department of have published the research work: Dabigatran Added to Dual Antiplatelet Therapy to Treat a Left Ventricular Thrombus in an 87 Year Old Patient With Myocardial Infarction and Very High Bleeding Risk, in the Journal: (JOURNAL)
- what: This study showed a lower risk of bleeding and equal risk of thromboembolic events using dual therapy in patients with atrial fibrillation after percutaneous coronary intervention (PCI) with dabigatran (110 or 150 mg twice daily) and a P2Y12 inhibitor (clopidogrel or ticagrelor . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.